Network origin in Vincent Dequenne first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
17
| Public Company | Biotechnology | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Vincent Dequenne via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SEQUANS COMMUNICATIONS S.A. | Semiconductors | Director/Board Member | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
| STALLERGENES | Pharmaceuticals: Major | Director of Finance/CFO | |
Groupe Limagrain Holding SA
 Groupe Limagrain Holding SA Agricultural Commodities/MillingProcess Industries Groupe Limagrain Holding SA engages in agricultural production. It offers wheat, corn, maize, sunflower, rapeseed, tomato, carrot, melon, cauliflower, and pepper, as well as flower seeds. The company was founded in 1965 and is headquartered in Saint-Beauzire, France. | Agricultural Commodities/Milling | Director/Board Member | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer | |
Groupe Grimaud La Corbière SA
 Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Chief Executive Officer Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
| University of Gottingen | College/University | Doctorate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Undergraduate Degree | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member | |
Pepscan Holding NV
 Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pepscan Therapeutics BV
 Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fonds Stratégique d'Investissement Fund
 Fonds Stratégique d'Investissement Fund Investment ManagersFinance Fonds Stratégique d'Investissement was created by the French Government in 2008 and integrated BPIFrance on 2013. This fund invests in small and middle sized French companies. | Investment Managers | Chief Investment Officer | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member | |
GSK Vaccines GmbH
 GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GSK Vaccines GmbH is a German company that manufactures and distributes pharmaceutical products. The private company is based in Marburg, Germany. The company was founded in 2009. Christopher Hunley has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chief Executive Officer | |
| Technische Hochschule Mittelhessen | College/University | Graduate Degree | |
| SBS Swiss Business School | College/University | Masters Business Admin | |
Devialet SA
 Devialet SA Electronics/AppliancesConsumer Durables Devialet SA manufactures audio integrated amplifiers. Its products include Devialet 120, Devialet 400, Devialet 200, and Devialet 800. The firm also offers home audio amplification system called Devialet ensemble, D-Premier, and Devialet 250. The company was founded by Pierre-Emmanuel Calmel, Mathias Moronvalle, Emmanuel Nardin, and Quentin Sannié in 2007 and is headquartered in Paris, France. | Electronics/Appliances | Director/Board Member | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman | |
| PIXIUM VISION | Medical Specialties | Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| Bpifrance Participations SA | Financial Conglomerates | Chief Investment Officer | |
| Grimaud Deyang Animal Co. Ltd. | Chairman Director/Board Member | ||
| Chengdu Grimaud Breeding Co. Ltd. | Chairman Director/Board Member | ||
Doctolib SAS
 Doctolib SAS Packaged SoftwareTechnology Services Doctolib SAS develops software for the health industry. This software improves the efficiency of hospitals and reinforces the cooperation with colleagues. The company was founded by Ivan Schneider, Jessy Bernal, and Stanislas Niox-Chateau on August 5, 2013 and is headquartered in Levallois-Perret, France. | Packaged Software | Director/Board Member | |
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The private company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| Elatos GmbH | Chief Executive Officer | ||
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The private company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
Cornovum SASU
 Cornovum SASU Financial ConglomeratesFinance Cornovum SASU is an investment holding French company. The company is based in Paris, France. The company was founded in 2015. The CEO is Maïlys Ferrère. | Financial Conglomerates | Chief Executive Officer | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Intercell Austria AG | Director/Board Member Corporate Officer/Principal Chief Executive Officer | ||
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The private company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The private company is based in Kirkland, Canada. | Medical Distributors | President Director/Board Member | |
| Grätzelmixer GmbH | Chief Executive Officer | ||
| Valneva USA, Inc. | Chief Executive Officer Chief Executive Officer | ||
Pays de la Loire Participations
 Pays de la Loire Participations Investment ManagersFinance Investissement pour le Développement des Entreprises l'Emploi is designed to invest in small and mid cap companies based in the Pays de la Loire region of France. The fund will invest mainly in innovative companies with a profitable track record and help them in their growth by taking minority participation. | Investment Managers | Director/Board Member |
Statistics
International
| France | 25 |
| United States | 6 |
| Austria | 6 |
| Germany | 4 |
| Netherlands | 3 |
Sectoral
| Health Technology | 20 |
| Finance | 9 |
| Consumer Services | 6 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operational
| Director/Board Member | 89 |
| Corporate Officer/Principal | 41 |
| Chief Executive Officer | 30 |
| Chairman | 28 |
| President | 27 |
Most connected contacts
| Insiders | |
|---|---|
| Frédéric Grimaud | 33 |
| James Sulat | 23 |
| Franck Grimaud | 22 |
| Anne-Marie Graffin | 22 |
| Sharon Tetlow | 21 |
| Maïlys Ferrère | 21 |
| Thomas Lingelbach | 17 |
| Peter Buhler | 14 |
| Jim Connolly | 12 |
| Kathrin Jansen | 7 |
| Frédéric Jacotot | 6 |
| Juan Carlos Jaramillo | 5 |
| Johanna Willemina Pattenier | 4 |
| Klaus Schwamborn | 4 |
| Dipal Patel | 4 |
- Stock Market
- Insiders
- Vincent Dequenne
- Company connections
